Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1544227 · TPST

Tempest Therapeutics, Inc.

Filing with the SEC SEC-reporting company Brisbane, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Nov 6, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Several leadership changes7 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Change in controlOn Feb 6, 2026 the company reported a change in control (Item 5.01).
  • Net loss in 2025Net loss of $26.3M for the year (2024: −$41.8M).
  • Private capital raiseOn Oct 14, 2026 the company filed Form D: $7.5M offered · $7.5M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$26.3M−$41.8M
Total assets$16.9M$41.5M
Total liabilities$10.3M$22.4M
Stockholders’ equity$6.7M$19.1M
Cash and equivalents$7.7M$30.3M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Tempest Therapeutics, Inc.
Formerly: Millendo Therapeutics, Inc.
CIK
0001544227
Tickers
TPST
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Legal form
Corporation
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Brisbane, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Latest exempt offering
$7.5M offered · $7.5M sold
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 30, 2026 · filing
  • Director or officer change: Director change
    Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 19, 2026 · filing
  • Private raise (Form D): $7.5M offered · $7.5M sold · Biotechnology
    Form D · items 06B · filed Oct 14, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 7.01, 9.01 · filed Sep 28, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Aug 24, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Aug 21, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 23, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jun 4, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 29, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 22, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 22, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Apr 3, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 30, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 30, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Feb 10, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 5.01, 5.02, 9.01 · filed Feb 6, 2026 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 3.02, 5.01, 5.02, 9.01 · filed Feb 6, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 5.01, 5.02, 9.01 · filed Feb 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 3.03, 5.02, 5.07 · filed Jan 28, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 9, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 9, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 8.01, 9.01 · filed Nov 19, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 5, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 5, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 11, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jun 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 13, 2025 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05 · filed Apr 18, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 27, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 27, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Dec 31, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 8, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 8, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 19, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 19, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 8, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 8, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 8, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 7, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 10, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07 · filed Jun 16, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 10, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 22, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 22, 2023 · filing